|4May 5, 4:54 PM ET

Karachun Rita A 4

4 · Merck & Co., Inc. · Filed May 5, 2023

Insider Transaction Report

Form 4
Period: 2023-05-03
Karachun Rita A
Sr. VP Fince-Global Controller
Transactions
  • Tax Payment

    Common Stock

    2023-05-03$117.89/sh276$32,53845,086.972 total
  • Exercise/Conversion

    Common Stock

    2023-05-03$117.89/sh+803$94,66645,362.972 total
  • Exercise/Conversion

    Common Stock

    2023-05-04$118.22/sh+949$112,19146,035.972 total
  • Tax Payment

    Common Stock

    2023-05-04$118.22/sh326$38,54045,709.972 total
  • Exercise/Conversion

    Common Stock

    2023-05-04$62.07/sh+15,875$985,36161,584.972 total
  • Sale

    Common Stock

    2023-05-04$117.53/sh15,875$1,865,84345,709.972 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-05-038031,608 total
    From: 2023-05-03Exp: 2025-05-03Common Stock (803 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2023-05-04949951 total
    From: 2022-05-04Exp: 2024-05-04Common Stock (949 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-05-0415,8750 total
    Exercise: $62.07From: 2018-05-05Exp: 2027-05-04Common Stock (15,875 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
  • [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
  • [F5]The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT